Owner Schering Oy

Inventors Keinanen, Antti; Ahola, Manja; AlaSorvari, Juha; Aaltonen, Marko; Haapakumpu, Timo

Agent Griffith Hack

Pub. Number AU-B-2002313517

PCT Number PCT/FI02/00692

PCT Pub. Number WO2003/017971

Priority 60/315,972 31.08.01 US

Filing date 27 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 6 September 2007

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees